CHRS
Coherus Oncology, Inc. · Healthcare
Director James Healy sold $6.8M of Coherus Oncology, Inc.
Sold$6,777,068
$21.37Price
317,130Shares
−12%Stake
What CHRS did after the filing
Prices for CHRS after this filing aren't in yet.
Traded Thu, Jun 20. Filed Mon, Jun 24, 6:30 PM ET, after the close. Not investment advice.